1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2017-2028)
2.2 Gastrointestinal Stromal Tumor Growth Trends by Region
2.2.1 Gastrointestinal Stromal Tumor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gastrointestinal Stromal Tumor Historic Market Size by Region (2017-2022)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2023-2028)
2.3 Gastrointestinal Stromal Tumor Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2017-2022)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2017-2022)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2021
3.5 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2017-2022)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2017-2022)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2017-2028)
6.2 North America Gastrointestinal Stromal Tumor Market Size by Country (2017-2022)
6.3 North America Gastrointestinal Stromal Tumor Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2017-2028)
7.2 Europe Gastrointestinal Stromal Tumor Market Size by Country (2017-2022)
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2017-2028)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Country (2017-2022)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2017-2028)
9.2 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2017-2022)
9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2017-2028)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2017-2022)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2017-2022)
11.1.5 Novartis Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Detail
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2017-2022)
11.2.5 Sun Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Detail
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2017-2022)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Detail
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2017-2022)
11.5.5 NATCO Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Stomach
Table 3. Key Players of Small Intestine
Table 4. Key Players of Others
Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Gastrointestinal Stromal Tumor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Gastrointestinal Stromal Tumor Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Gastrointestinal Stromal Tumor Market Share by Region (2017-2022)
Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Gastrointestinal Stromal Tumor Market Share by Region (2023-2028)
Table 11. Gastrointestinal Stromal Tumor Market Trends
Table 12. Gastrointestinal Stromal Tumor Market Drivers
Table 13. Gastrointestinal Stromal Tumor Market Challenges
Table 14. Gastrointestinal Stromal Tumor Market Restraints
Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Gastrointestinal Stromal Tumor Market Share by Players (2017-2022)
Table 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2021)
Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastrointestinal Stromal Tumor Product Solution and Service
Table 22. Date of Enter into Gastrointestinal Stromal Tumor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2017-2022)
Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2023-2028)
Table 28. Global Gastrointestinal Stromal Tumor Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2017-2022)
Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2023-2028)
Table 32. North America Gastrointestinal Stromal Tumor Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Gastrointestinal Stromal Tumor Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Gastrointestinal Stromal Tumor Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Gastrointestinal Stromal Tumor Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2023-2028) & (US$ Million)
Table 42. Novartis Company Detail
Table 43. Novartis Business Overview
Table 44. Novartis Gastrointestinal Stromal Tumor Product
Table 45. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2017-2022) & (US$ Million)
Table 46. Novartis Recent Development
Table 47. Sun Pharmaceutical Company Detail
Table 48. Sun Pharmaceutical Business Overview
Table 49. Sun Pharmaceutical Gastrointestinal Stromal Tumor Product
Table 50. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2017-2022) & (US$ Million)
Table 51. Sun Pharmaceutical Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Gastrointestinal Stromal Tumor Product
Table 55. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2017-2022) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Bayer Aktiengesellschaft Company Detail
Table 58. Bayer Aktiengesellschaft Business Overview
Table 59. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product
Table 60. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2017-2022) & (US$ Million)
Table 61. Bayer Aktiengesellschaft Recent Development
Table 62. NATCO Pharma Company Detail
Table 63. NATCO Pharma Business Overview
Table 64. NATCO Pharma Gastrointestinal Stromal Tumor Product
Table 65. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2017-2022) & (US$ Million)
Table 66. NATCO Pharma Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Market Share by Type: 2021 VS 2028
Figure 2. Stomach Features
Figure 3. Small Intestine Features
Figure 4. Others Features
Figure 5. Global Gastrointestinal Stromal Tumor Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Specialized Cancer Treatment Centers Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Gastrointestinal Stromal Tumor Report Years Considered
Figure 11. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Gastrointestinal Stromal Tumor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Gastrointestinal Stromal Tumor Market Share by Region: 2021 VS 2028
Figure 14. Global Gastrointestinal Stromal Tumor Market Share by Players in 2021
Figure 15. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2021
Figure 17. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Gastrointestinal Stromal Tumor Market Share by Country (2017-2028)
Figure 19. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Gastrointestinal Stromal Tumor Market Share by Country (2017-2028)
Figure 23. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Region (2017-2028)
Figure 31. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Gastrointestinal Stromal Tumor Market Share by Country (2017-2028)
Figure 39. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Country (2017-2028)
Figure 43. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2017-2022)
Figure 46. Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2017-2022)
Figure 48. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2017-2022)
Figure 49. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Sun Pharmaceutical Pfizer Bayer Aktiengesellschaft NATCO Pharma